About Chiesi Pharmaceuticals
Chiesi Pharmaceuticals is a company based in Parma (Italy) founded in 1935. Chiesi Pharmaceuticals has completed 6 acquisitions, including Amryt Pharma, Atopix Therapeutics and Cornerstone Therapeutics.
- Headquarter Parma, Italy
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$437.48 K (USD), Grant
Nov 23, 2023
- Investors
-
Employee Count
Not available
-
Investments & Acquisitions
Amryt Pharma
& 5 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Chiesi Pharmaceuticals
Unlock access to complete
Unlock access to complete
Software Development Team
36 people
Human Resources and Administration
27 people
Legal and Compliance
22 people
Finance and Accounting
17 people
Sales and Marketing
14 people
Head Team
9 people
Board Team
8 people
Global Team
8 people
Unlock access to complete
Funding Insights of Chiesi Pharmaceuticals
Investors in Chiesi Pharmaceuticals
Chiesi Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Chiesi Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Chiesi Pharmaceuticals
Chiesi Pharmaceuticals has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Amryt Pharma, Atopix Therapeutics and Cornerstone Therapeutics.
Investment portfolio details for Chiesi Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapeutics for rare dermatological and orphan diseases are developed.
|
Locked | Locked | 2015 | Locked | |
|
Medicines to treat atopic dermatitis and severe asthma
|
Locked | Locked | 2012 | Locked | |
|
Therapies for hereditary angioedema and diabetic macular edema based on small molecule plasma kallikrein inhibitors
|
Locked | Locked | 2011 | Locked |
Complete acquisition details for Chiesi Pharmaceuticals
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Chiesi Pharmaceuticals
Detailed financials for Chiesi Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Chiesi Pharmaceuticals Comparisons
Peer comparison for Chiesi Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Chiesi Pharmaceuticals
Detailed competitors of Chiesi Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Chiesi Pharmaceuticals
Complete news archive for Chiesi Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chiesi Pharmaceuticals
Chiesi Pharmaceuticals was founded in 1935 and raised its 1st funding round 84 years after it was founded.
Chiesi Pharmaceuticals is headquartered in Parma, Italy. It is registered at Parma, Emilia-romagna, Italy.
Giuseppe Accogli is the current CEO of Chiesi Pharmaceuticals.
Founded in 1935 in Parma, Italy, Chiesi Pharmaceuticals operates in the pharmaceutical sector, with a focus on therapeutics for respiratory conditions, neonatology, rare diseases, and special care. Respiratory programs target asthma and chronic obstructive pulmonary disease through new chemical entities and reformulated anti-inflammatory and bronchodilator treatments. In neonatology, Curosurf is advanced for neonatal respiratory distress syndrome in late-stage trials.
Chiesi Pharmaceuticals has made 6 acquisitions, including Amryt Pharma, Atopix Therapeutics, and Cornerstone Therapeutics.
Chiesi Pharmaceuticals has 1 investor. Key investors include European Union.